What's new in CF airway inflammation: An update

Paediatric Respiratory Reviews

Volumn 7, Issue SUPPL. 1, 2006, Pages

  Ratjen, Felix ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

airway inflammation; anti inflammatory treatment; bronchoalveolar lavage; cystic fibrosis

Indexed keywords

ALPHA 1 ANTITRYPSIN; CORTICOSTEROID; DEOXYRIBONUCLEASE; ELASTASE; ELASTASE INHIBITOR; GLUTATHIONE; IBUPROFEN; INTERLEUKIN 8; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; NITRIC OXIDE; PROTEINASE INHIBITOR; RECOMBINANT DEOXYRIBONUCLEASE; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; BRONCHUS HYPERREACTIVITY; CLINICAL FEATURE; CLINICAL TRIAL; COOPERATION; CYSTIC FIBROSIS; DISEASE EXACERBATION; EXHALATION; FEASIBILITY STUDY; HUMAN; LUNG CLEARANCE; LUNG FIBROSIS; LUNG FUNCTION; LUNG LAVAGE; MUCUS SECRETION; MUTATIONAL ANALYSIS; NEUTROPHIL CHEMOTAXIS; NON INVASIVE PROCEDURE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INFLAMMATION; REVIEW; RISK FACTOR; SPUTUM ANALYSIS;

ANIMALS; BRONCHOALVEOLAR LAVAGE; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMANS; INFLAMMATION; MUTATION; NITRIC OXIDE; PROGNOSIS;

EID: 33745191871     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2006.04.170     Document Type: Review

References (31)

1. Ratjen F., and Döring G. Cystic fibrosis. Lancet 361 (2003) 681-689
2. Gibson R.L., Burns J.L., and Ramsey B.W. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168 (2003) 918-951
3. Armstrong D.S., Hook S.M., Jamsen K.M., Nixon G.M., Carzino R., Carlin J.B., Robertson C.F., and Grimwood K. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening. Pediatr Pulmonol 40 (2005) 500-510
4. Weber A.J., Soong G., Bryan R., Saba S., and Prince A. Activation of NF-kappaB in airway epithelial cells is dependent on CFTR trafficking and Cl- channel function. Am J Physiol Lung Cell Mol Physiol 281 (2001) L71-L78
5. Kube D., Sontich U., Fletcher D., and Davis P.B. Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines. Am J Physiol Lung Cell Mol Physiol 280 (2001) L493-L502
6. Aldallal N., McNaughton E.E., Manzel L.J., Richards A.M., Zabner J., Ferkol T.W., and Look D.C. Inflammatory response in airway epithelial cells isolated from patients with cystic fibrosis. Am J Respir Crit Care Med 166 (2002, Nov 1) 1248-1256
7. Becker M.N., Sauer M.S., Muhlebach M.S., Hirsh A.J., Wu Q., Verghese M.W., and Randell S.H. Cytokine secretion by cystic fibrosis airway epithelial cells. Am J Respir Crit Care Med 169 (2004) 645-653
8. van Heeckeren A.M., Schluchter M.D., Xue W., and Davis P.B. Response to Acute Lung Infection with Mucoid Pseudomonas aeruginosa in Cystic Fibrosis Mice. Am J Respir Crit Care Med 173 (2006) 288-296
9. Tirouvanziam R., de Bentzmann S., Hubeau C., Hinnrasky J., Jacquot J., Peault B., and Puchelle E. Inflammation and infection in naive human cystic fibrosis airway grafts. Am J Respir Cell Mol Biol 23 (2000) 121-127
10. Hubeau C., Lorenzato M., Couetil J.P., Hubert D., Dusser D., Puchelle E., and Gaillard D. Quantitative analysis of inflammatory cells infiltrating the cystic fibrosis airway mucosa. Clin Exp Immunol 124 (2001 Apr) 69-76
11. Bonfield T.L., Konstan M.W., Burfeind P., Panuska J.R., Hilliard J.B., and Berger M. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol 13 (1995) 257-261
12. Armstrong D., Grimwood K., Carlin J.B., Carzino R., Hull J., Olinsky A., and Phelan P.D. Severe viral respiratory infections in infants with cystic fibrosis. Pediatr Pulmonol 26 (1998) 371-379
13. Konstan M.W., Hilliard K.A., Norvell T.M., et al. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 150 (1994) 448-454
14. Khan T.Z., Wagener J.S., Bost T., Martinez J., Accurso J.F., and Riches D.W.H. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 151 (1995) 1075-1082
15. Armstrong D.S., Grimwood K., Carzino R., et al. Lower respiratory infection and inflammation in newly diagnosed cystic fibrosis. BMJ 310 (1995) 1571-1572
16. Muhlebach M.S., Stewart P.W., Leigh M.W., and Noah T.L. Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med 160 (1999) 186-191
17. Paul K., Rietschel E., Ballmann M., Griese M., Worlitzsch D., Shute J., Chen C., Schink T., Döring G., van Koningsbruggen S., Wahn U., Ratjen F., and for the BEAT Study Group. Effect of dornase alpha on airway inflammation in cystic fibrosis. Am J Respir Care Med 169 (2004) 719-725
18. Grasemann H., Michler E., Wallot M., and Ratjen F. Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis. Pediatr Pulmonol 24 (1997) 173-177
19. Grasemann H., and Ratjen F. Cystic fibrosis lung disease: the role of nitric oxide. Pediatr Pulmonol 28 (1999) 442-448
20. Carpagnano G.E., Barnes P.J., Francis J., Wilson N., Bush A., and Kharitonov S.A. Breath condensate pH in children with cystic fibrosis and asthma: a new noninvasive marker of airway inflammation?. Chest 125 (2004) 2005-2010
21. Bodini A., D'Orazio C., Peroni D., Corradi M., Folesani G., Baraldi E., Assael B.M., Boner A., and Piacentini G.L. Biomarkers of neutrophilic inflammation in exhaled air of cystic fibrosis children with bacterial airway infections. Pediatr Pulmonol 40 (2005) 494-499
22. Reinhardt N., Chen C.I., Loppow D., Schink T., Kleinau I., Jorres R.A., Wahn U., Magnussen H., and Paul K.P. Cellular profiles of induced sputum in children with stable cystic fibrosis: comparison with BAL. Eur Respir J 22 (2003) 497-502
23. Ordonez C.L., Henig N.R., Mayer-Hamblett N., Accurso F.J., Burns J.L., Chmiel J.F., Daines C.L., Gibson R.L., McNamara S., Retsch-Bogart G.Z., Zeitlin P.L., and Aitken M.L. Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis. Am J Respir Crit Care Med 168 (2003) 1471-1475
24. Ordonez C.L., Kartashov A.I., and Wohl M.E. Variability of markers of inflammation and infection in induced sputum in children with cystic fibrosis. J Pediatr 145 (2004) 689-692
25. Eigen H., Rosenstein B.J., Fitzsimmons S., et al. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. J Pediatr 126 (1995) 515-523
26. Lai H.C., FitzSimmons S.C., Allen D.B., et al. Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis. N Engl J Med 342 (2000) 851-859
27. Dezateux C, Walters S, Balfour-Lynn I. Inhaled corticosteroids for cystic fibrosis. Cochrane Database Syst Rev 2000; 2: CD001915.
28. Konstan M.W., Byard P.J., Hoppel C.L., et al. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med 332 (1995) 848-854
29. McElvaney N.G., Hubbard R.C., Birrer P., et al. Aerosol α1-antitrypsin treatment for cystic fibrosis. Lancet 337 (1991) 392-394
30. Martin S.L., Downey D., Bilton D., Keogan M.T., Edgar J., and Elborn J.S. Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis. Pediatr Pulmonol 41 (2006) 177-183
31. Griese M., Ramakers J., Krasselt A., Starosta V., Van Koningsbruggen S., Fischer R., Ratjen F., Mullinger B., Huber R.M., Maier K., Rietschel E., and Scheuch G. Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis. Am J Respir Crit Care Med 169 (2004) 822-828